Cannvas MedTech (CSE:MTEC) (“Cannvas” or the “Company”), a leading business technology company in the cannabis space, is pleased to announce its intent, operating under its newly-formed Cannvas Cannabis Acquisitions brand, to create a network of high-tech learning and fulfillment centres across Canada, improving accessibility to free and unbiased education about the potential benefits of medical and adult-use cannabis while providing curious consumers with on-site retail options from leading cannabis brands. Operating under the brand Cannvas Marché, each location will feature on-site medical and educational staff, digital learning resources and a fulfillment program, with the first centre expected to open in Toronto in early 2019.

“This is an exciting venture unlike anything being done in today’s market, benefitting active and potential medical and adult-use cannabis users by improving accessibility to free cannabis education while providing visitors to the centre with the opportunity for immediate fulfillment on-site,” said Steve Loutskou, Chief Operating Officer of Cannvas MedTech Inc and Chief Executive Officer of Cannvas Cannabis Acquisitions. “Our hope is that anyone of legal age will be able to visit their local Cannvas Marché, sit in on seminars pertaining to their lifestyle, speak with a health practitioner and, if they choose, interact with one of our retail partners to purchase cannabis products suited to their needs.”


Initial renderings for the Cannvas Marché concept are available at CannvasMarche.com and the Company has entered into a Memorandum of Understanding (MOU) with a leading finance incubator of licensed cannabis ventures as its strategic realtor to advise on viability of certain locations in the city’s downtown core for the first cannabis education and fulfillment centre. Each centre will feature hands-on education sessions on a variety of cannabis-related topics with no pressure to purchase or consume. Sessions will be led by a registered health practitioner or certified educator and showcase original physician-backed content created for the Cannvas.Me platform. Visitors can register for free seminars each week or drop in anytime to access the content on their own through tablets and touch-screens.

“It’s never easy being the first to do anything and we believe strongly in the mission of our Cannvas Marché concept to provide accessible and unbiased cannabis education to consumers at all stages of cannabis curiosity while ensuring the overall long-term viability of this learning and retail hub,” said Shawn Moniz, Chief Executive Officer of Cannvas MedTech. “We have worked diligently to evaluate all potential revenue streams and are pleased with our projections both in the short- and long-term, and look forward to bringing our network of strategic partners into this project should there be a fit.”

The unique aspect of the Cannvas Marché is its fulfillment aspect. Each centre will include a retail marketplace component featuring leading cannabis brands ready to fulfill the needs of consumers wishing to purchase cannabis products. The proprietary retail business model Cannvas has developed ensures the Company remains true to its mission of remaining unbiased and offering content with no hidden agenda. Cannvas has already engaged several brands and are in discussions to issue Letters of Intent (LOIs) in the near future.

“We’re taking what Apple does with its Genius Bar and learning seminars and applying it to the cannabis retail experience to offer Canadians a value-added educational experience as they explore the world of legalized cannabis,” said Daniel Davidzon, Marketing Manager for Cannvas MedTech Inc. “In taking the same approach to a bricks-and-mortar location as we do online, we’re able to offer visitors to our Cannvas Marché centres unparalleled access to reliable and relevant information, arming them with the knowledge they need to be confident in taking the next steps in their cannabis journey while adding value with an immediate option for fulfillment.”

Cannvas is currently engaging with top regulators and compliance bodies as it works aggressively to begin the first phase of creating this first-of-its-kind public cannabis education and fulfillment centre. Through a creative licensing model, the Company intends to expand the reach of its Cannvas Marché centres to communities across Canada and use its strategic partnerships to further integrate the Cannvas.Me platform into existing retail experiences.

The project speaks to the strengths of the Cannvas executive team and its wealth of experience across a range of sectors. Steve Loutskou, COO of Cannvas MedTech Inc and CEO of Cannvas Cannabis Acquisitions, brings a successful track record in real estate and technology while Shawn Moniz, CEO at Cannvas MedTech has an extensive background in pharmacy and experiential patient education. Cannvas has also retained Nick Pavlov as its real estate advisor to vet properties in downtown Toronto. A past member of the Diversity Task Force and panel member (professional standards) for the Toronto Real Estate Board, Nick supplies real estate and market guidance within the retail and commercial sphere for cannabis-based activities, has represented three of Canada’s chartered banks as their selling specialist and has appeared in media on HGTV, Global TV, CBC and various print outlets.

About Cannvas Cannabis Acquisitions

Cannvas Cannabis Acquisitions is a wholly-owned subsidiary of Cannvas MedTech Inc., with a focus on investment and acquisition in the expanding global cannabis sector. Cannvas Cannabis seeks to complement Cannvas’ current product offering through continuous development, strategic investments and acquisitions in the cannabis sector. Related companies may include, but are not limited to technology, marketing and design, food and nutraceuticals, regulation and enforcement, new product development, gear and paraphernalia, retail stores and dispensaries, and testing labs.

About Cannvas MedTech Inc.

Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation.

Source: www.newswire.ca

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less